Yuhan Corporation, a leading pharmaceutical company based in South Korea (KR), has been at the forefront of the industry since its establishment in 1926. With its headquarters in Seoul, Yuhan operates extensively across Asia, Europe, and North America, focusing on innovative drug development and manufacturing. Specialising in prescription pharmaceuticals, over-the-counter products, and biopharmaceuticals, Yuhan is renowned for its commitment to research and development, which has led to significant advancements in oncology, cardiology, and infectious diseases. The company has achieved notable milestones, including strategic partnerships and a robust pipeline of new therapies, solidifying its position as a key player in the global market. Yuhan Corporation's dedication to quality and innovation continues to drive its success, making it a trusted name in the pharmaceutical landscape.
How does Yuhan Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Yuhan Corporation's score of 35 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Yuhan Corporation reported total carbon emissions of approximately 7,756,000 kg CO2e for Scope 1 and about 16,818,000 kg CO2e for Scope 2, resulting in a combined total of around 24,564,000 kg CO2e for both scopes. This marks a slight decrease from 2022, where emissions were approximately 7,819,000 kg CO2e for Scope 1 and about 16,191,000 kg CO2e for Scope 2, totalling around 24,000,000 kg CO2e. In 2021, the company recorded emissions of about 7,492,000 kg CO2e for Scope 1 and approximately 15,246,000 kg CO2e for Scope 2, leading to a total of around 22,724,000 kg CO2e. Yuhan Corporation has committed to achieving net-zero greenhouse gas emissions by 2050, as part of its long-term climate strategy initiated in 2023. This commitment reflects the company's recognition of the urgent need for global cooperation in addressing climate change. Currently, Yuhan has not disclosed any Scope 3 emissions data, nor does it have specific Science-Based Targets Initiative (SBTi) targets. Overall, Yuhan Corporation is actively working towards reducing its carbon footprint while aiming for significant long-term sustainability goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 7,492,000 | 0,000,000 | 0,000,000 | 
| Scope 2 | 15,246,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Yuhan Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
